ACAD +17% on EU Approval
ACAD rises 17% premarket after DAYBU receives European Union approval recommendation from CHMP
Top Big Cap Positive News Movers Premarket: ACAD: +17% DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP SYNA: +5.5% onsemi to Acquire Synaptics WSE: +3% Earnings DKNG: +2.5% Launches Proprietary Exchange to Bolster Differentiated Predictions Experience